Drugs in the Pipeline
- 28 September 2018
- book chapter
- book charpter
- Published by Elsevier BV
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Advances in pharmacotherapy for the treatment of goutExpert Opinion on Pharmacotherapy, 2014
- Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparatorArthritis Research & Therapy, 2013
- Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensionsAnnals Of The Rheumatic Diseases, 2012
- Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised studyAnnals Of The Rheumatic Diseases, 2011
- Rilonacept and canakinumabBritish Journal of Clinical Pharmacology, 2011
- Mechanisms of inflammation in goutArthritis Research & Therapy, 2010
- CanakinumabmAbs, 2010
- A pilot study of IL-1 inhibition by anakinra in acute goutArthritis Research & Therapy, 2007
- Bucillamine induces glutathione biosynthesis via activation of the transcription factor Nrf2Biochemical Pharmacology, 2006
- Bucillamine: A Potent Thiol Donor with Multiple Clinical ApplicationsCardiovascular Drug Reviews, 2003